Renal denervation: back on track

References

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 365:217-223, 2005 https://doi.org/10.1016/S0140-6736(05)17741-1
2. Sarafidis PA, Li S, Chen SC, et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med 121:332-340, 2008 https://doi.org/10.1016/j.amjmed.2007.11.025
3. Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370:1393-1401, 2014 https://doi.org/10.1056/NEJMoa1402670
4. Townsend RR, Mahfoud F, Kandzari DE, et al. Catheterbased renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet 390:2160-2170, 2017 https://doi.org/10.1016/S0140-6736(17)32281-X
5. Kandzari DE, Bohm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet 391:2346-2355, 2018 https://doi.org/10.1016/S0140-6736(18)30951-6
6. Azizi M, Schmieder RE, Mahfoud F, et al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, singleblind, randomised, sham-controlled trial. Lancet 391:2335-2345, 2018 https://doi.org/10.1016/S0140-6736(18)31082-1